You are here

Home » Content

Çocuklarda Febril Nötropeni

Febril Neutropenia in Children

Journal Name:

  • Uludağ Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2003

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Infections are important causes of morbidity and mortality in neutropenic patients with cancer. Duration of neutropenia and absolute neutrophil count are important factors affecting infection risk. In febril neutropenic children, mostly seen infectious agents are bacteria. However, virus, fungus and parasites are also isolated from febril neutropenic patients in less frequency. In this review, etiologic agents, diagnosis and treatment of febril neutropenia in children are discussed.
Bookmark/Search this post with
Abstract (Original Language): 
Kanserli nötropenik hastalarda infeksiyonlar önemli morbidite ve mortalite nedenidir. Nötropeninin süresi ve mutlak nötrofil sayısı infeksiyon riskini etkileyen önemli faktörlerdir. Febril nötropenili çocuklarda görülen enfeksiyonların etkenleri çoğu kez bakteriler olmakla birlikte viruslar, mantar ve parazitler de etken olarak izole edilmektedir. Bu yazıda çocuklarda febril nötropenide etiyoloji, tanı ve tedavi tartışılmıştır
FULL TEXT (PDF): 
PDF icon arastirmax-cocuklarda-febril-notropeni.pdf
  • 2
35-41
  • Turkish

REFERENCES

References: 

1. Giamarellou H, Antoniadou A. Infectious Complications of
Febrile Leukopenia. In; Robert C, Moellering (ed). Infectious
Disease Clinics of North America. W.B. Saunders Company,
Philadelphia; 2001. 457-482.
2. Akova M. Kanserli nötropenik ateşli hastaya yaklaşım. Hacettepe Tıp Dergisi 1995; 26 (1): 31-36.
3. American Society of Clinical Oncology: Update of
recommendations for the use of hematopoetic colonystimulating factors: Evidence- based, clinical practice
guidelines. J Clin Oncol 1996; 14: 1957-1960.
4. Schimpff S. Empric antibiotic therapy for granulocytopenic
patients. Am J Med 1989; 80(5c): 13-20.
5. Anaissie E. Oppurtunistic mycoses in the
immunocompromised host: Experience at a cancer center and
review. Clin Infect Dis 1992; 14 (1): 43-53.
6. Giamarellos H. Infection in febrile neutropenia. In: Cunha BA
(ed): Infectious Diseases in Critical Care Medicine. New
York, Marcel Dekker; 1998. 563.
7. Bodey GP. Dermatologic manifestations of infections in
neutropenic patients. Med Clin North Am 1994; 8: 665-675.
8. Stoupis A, Zinner SH. Approach to fever in the neutropenic
host. In: Noskin GA (ed): Management of Infectious
Complications Cancer Patients. Boston, Kluwer Academic
Publishers; 1998. 77.
9. Pizzo PA. Management of fever in patients with cancer and
treatment induced neutropenia. NEngl J Med 1993; 328
(18):1323-1332.
10. Pizzo PA, Rubin M. Infectious complications in children with
haematologic disorders. In: Nathan DG, Oski FA (eds). Oski
Pediatric Haematology. 4
th
edition. W.B. Saunders Company,
Philadelphia; 1994. 1730-1749.
11. Zinner SH. Changing epidemiology of infections in patients
with neutropenia and cancer: Emphasis on gram-positive and
resistant bacteria. Clin Infect Dis 1999; 29: 490-494.
12. Gürler N. Febril nötropenili çocuklarda mikrobiyolojik tanı
yaklaşımı. Ankem Derg 2001; 15 (3): 500-507.
13. Caillot D, Casasnovas O, Bernard A, et al. Improved
management of invasive aspergilosis in neutropenic patients
using early thoracic computed tomographic scan and surgery.
J Clin Oncol 1997; 15:139-147.
14. Oppenheim BA. The changing pattern of infections in
neutropenic patients. N Antimicrob Chemother 1998; 41: 7-
12.
15. Shamberger RC, Weinstein HJ, Delorey MJ, et al. The
Medical and Surgical Management of Typhlitis in Children
With Acute Nonlymphocytic (Myelogenous) Leukemia.
Cancer 1986; 57: 603-609.
16. Bodey GP, Buckley M, Sathe Y, et al. Quantitative
relationships between circulating leukocytes and infection in
patients with acute leukemia. Ann Intern Med 1996; 64: 328-
340.
17. Rolston KVI: New trends in patients management. Risk-based
therapy for febrile patients with neutropenia. Clin Infect Dis
199; 29: 515-521.
18. Davies JM. A survey of the use of teicoplanin in patients with
haematological malignancies and solid tumors. Infection
1998; 44: 389-395.
19. De Pauw BE, Meunier F. Infections in patients with acute
leukemia and lymphoma. In: Mandell GL, Bennet JE, Dolin R
(eds): Principles and Practice of Infectious Disease. 5
th
edition.
Philadelphia, Churchill Livingstone; 2000. 3090.
20. Yurdakök M, Ceyhan M. Ateşli nötropenik hastayı değerlendirme. Pediatride yeni bilgiler ve görüşler. Güneş Kitabevi. I.
Baskı. 1995. 181-190.
21. Finkbiner KL, Enrst TF. Drug therapy management of the
febrile neutropenic cancer patient. Cancer Practice 1993; 1(4):
295-303.
22. Swertloff JN, Filler SG, Edwards JE. Severe candidal
infections in neutropenic patients. Clin Infect Dis 1993; 17
(2): 457-67.
23. Bodey GP, Bueltmann B, Duguid W, et al. Fungal infections
in cancer patients: An international autopsy survey. Eur J Clin
Microbiol Infect Dis 1992; 11:99-109.
24. Jones RN. Contemporary antimicrobial susceptibility patterns
of bacterial pathogens commonly associated with febrile
patients with neutropenia. Clin Infect Dis 1999; 29: 495-502.
25. De Marie S. New developments in the diagnosis and
management of invasive fungal infections. Haematologica
2000; 85: 88-93.
26. Çetingül N. Febril nötropenili hastalarda solunum sistemi
infeksiyonlarına yaklaşım. Ankem Derg 2001; 15 (3): 515-
520.
27. Kebudi R. Febril nötropenili çocuklarda empirik tedavi yakla-
şımı. Ankem Derg 1998; 12 (3): 360-364. Çocuklarda Febril Nötropeni
41
28. Kebudi R. Düşük riskli ateşli nötropenik çocuklarda ampirik
tedavi. Ankem Derg 2001; 15 (3): 508-514.
29. Walter T, Donald A, Bodey GP, et al. 2002 Guidelines for the
Use of Antimicrobial Agents in Neutropenic Patients with
Cancer. CID 2002; 34; 730-751.
30. Kern WV, Cometta A, de Bock R, Langenacken J, Paesmans
M, Gaya H. for the IATCG of EORTC: Oral versus
intravenous empirical antimicrobial therapy for fever in
patients with granulocytopenia who are receiving cancer
chemotherapy. N Engl J Med 1999; 341: 312.
31. Günay Ü, Tanrıtanır A, Meral A, Sevinir, Hacımustafaoğlu M.
Nötropenik ateşli çocuklarda granülosit-koloni stimülan faktör
(G- CSF) ve intravenöz immünoglobülin etkinliği. Çocuk Sağ-
lığı ve Hastalıkları Dergisi 1998; 41: 433-444.

Thank you for copying data from http://www.arastirmax.com